Trial Profile
Retrospective cohort study comparing outcomes of bleeding complications in patients treated with warfarin or dabigatran or rivaroxaban
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Feb 2016
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Dabigatran etexilate; Warfarin
- Indications Embolism and thrombosis
- Focus Adverse reactions
- 14 Feb 2016 New trial record